Stereotactic ablative radiotherapy (SABR) is an addition to the armamentarium against cancer. The technical requirements for SABR are very stringent, given its very narrow therapeutic window. However, when the principles are strictly followed, it is possible to deliver SABR to extracranial tumours safely and effectively.
|Original language||English (US)|
|Number of pages||4|
|Journal||journal of medical radiation sciences|
|State||Published - Mar 2016|